Hainan Daily Hainan Cancer Hospital Introduces New Technology, Bringing New Approach to the Treatment of Advanced Prostate Cancer
hinews.cn "Missile-style" precision strike! This new technology specializes in treating refractory advanced prostate cancer
Haiba News Hainan Cancer Hospital Introduces New Technology to Specialize in Treating Refractory Advanced Prostate Cancer
People's Daily Online Hainan Cancer Hospital Introduces New Technology for Precision Treatment of Advanced Prostate Cancer
Consumption Daily Hainan Cancer Hospital Introduces Innovative Targeted Radionuclide Therapy Technology to Specialize in Prostate Cancer
Consumption Daily The Department of Rehabilitation Medicine at Hainan Cancer Hospital offers three core services to address diverse rehabilitation needs
hinews.cn 95-year-old hip fracture patient successfully underwent complex joint replacement surgery by the orthopedic team at Hainan Chengmei Hospital
Consumption Daily Hainan Cancer Hospital Embarks on a New Journey of Joint Construction with Medical Schools; High School Students Explore the Hospital and Understand the Original Intent of Medical Practitioners
Haiba News A Man's Airway Was "Blocked" and a New Type of Stent "Held Open" the Life Channel
Hainan Daily 95-year-old hip fracture patient successfully underwent complex joint replacement surgery by the orthopedic team at Hainan Chengmei Hospital
Chief Physician
Skilled in precise radiotherapy for head and neck malignant tumors as well as stereotactic radiotherapy for tumors of various solid organs, with profound expertise in nasopharyngeal cancer and head and neck cancer. The overall survival rate of nasopharyngeal cancer patients treated by our team is comparable to that of domestic head radiotherapy centers. Proficient in formulating comprehensive treatment plans and managing the entire treatment process for head and neck cancer; adept at devising and planning comprehensive treatment strategies for chest and digestive system tumors, as well as formulating comprehensive treatment plans for various malignant tumors.
Specializes in precise radiotherapy for head and neck malignant tumors as well as stereotactic radiotherapy for tumors of various solid organs. Has profound expertise in nasopharyngeal cancer and head and neck cancer. The overall survival rate of nasopharyngeal cancer patients treated by the team is comparable to that of domestic head radiotherapy centers. Skilled in formulating comprehensive treatment plans and managing the entire treatment process for head and neck cancer. Proficient in developing and planning comprehensive treatment strategies for thoracic and digestive system tumors, as well as formulating comprehensive treatment plans for various malignant tumors.
Basic and clinical research on radiotherapy and chemotherapy for malignant tumors.
I. Deputy Head of the Mediastinal Tumor Group, Radiation Oncology Branch, Chinese Medical Doctor Association
II. Standing Committee Member of the Molecular Targeting and Immunotherapy Specialty Committee of the Hainan Provincial Anti-Cancer Association
III. Member of the First Committee of the Radiotherapy Specialty Committee of the Hainan Provincial Cancer Prevention and Treatment Association
IV. Member of the Radiation Oncology Branch Committee of the Hainan Provincial Medical Association
V. Member of the First Committee of the Radiotherapy Specialty of the Hainan Provincial Anti-Cancer Association
VI. Member of the Lung Cancer Professional Committee of the Hainan Provincial Cancer Prevention and Control Association
VII. Member of the Parenteral and Enteral Nutrition Branch Committee of the Hainan Provincial Medical Association
VIII. Vice Chairman of the First Committee of the Adverse Drug Reaction Specialty Committee of the Hainan Provincial Cancer Prevention and Treatment Association
IX. Member of the Youth Committee of the Oncology Branch Committee of the Hainan Provincial Medical Association
X. Member of the Expert Committee of the Medical Quality Control Center for Radiotherapy Specialty in Hainan Province (June 2023 - December 2024)
XI. Vice Chairman of the First Committee of the Adverse Drug Reaction Specialty Committee of the Hainan Provincial Anti-Cancer Association
XII. Executive member of the Precision Radiotherapy and Comprehensive Treatment Professional Committee of the Hainan Provincial Anti-Cancer Association
